IDEXX LABORATORIES INC /DE — Director's Dealing 2019

Feb 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2019-02-14

Reporting Person: Lane Michael (Corporate Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-14	Common Stock	M	242	—	Acquired	3623	Direct
2019-02-14	Common Stock	M	188	—	Acquired	3811	Direct
2019-02-14	Common Stock	M	221	—	Acquired	4032	Direct
2019-02-14	Common Stock	M	212	—	Acquired	4244	Direct
2019-02-14	Common Stock	M	197	—	Acquired	4441	Direct
2019-02-14	Common Stock	F	324	$206.94	Disposed	4117	Direct
2019-02-15	Common Stock	S	971	$208	Disposed	3146	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-14	Non-Qualified Stock Option (right-to-buy)	$206.94	M	8366	Acquired	2029-02-13	Common Stock (8366)	Direct
2019-02-14	Incentive Stock Option (right-to-buy)	$206.94	M	483	Acquired	2029-02-13	Common Stock (483)	Direct
2019-02-14	Restricted Stock Unit	$	M	906	Acquired		Common Stock (906)	Direct
2019-02-14	Restricted Stock Unit	$	M	242	Disposed		Common Stock (242)	Direct
2019-02-14	Restricted Stock Unit	$	M	188	Disposed		Common Stock (188)	Direct
2019-02-14	Restricted Stock Unit	$	M	221	Disposed		Common Stock (221)	Direct
2019-02-14	Restricted Stock Unit	$	M	212	Disposed		Common Stock (212)	Direct
2019-02-14	Restricted Stock Unit	$	M	197	Disposed		Common Stock (197)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	592	Indirect

Footnotes

F1: Includes a total of 48 shares purchased under the Issuer's Employee Stock Purchase Plan on September 28, 2018 and December 31, 2018.

F2: Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary
interest therein.

F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020.

F4: Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant.

F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").

F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split.

F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017.

F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.

F10: 9. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.

F11: Not applicable.